Diabetic Retinopathy Market Size, Share, and Trends 2024 to 2034

The global diabetic retinopathy market size accounted for USD 10.23 billion in 2025 and is forecasted to hit around USD 17.91 billion by 2034, representing a CAGR of 6.42% from 2025 to 2034. The North America market size was estimated at USD 3.65 billion in 2024 and is expanding at a CAGR of 6.56% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

  • Last Updated : March 2025
  • Report Code : 3954
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Diabetic Retinopathy Market 

5.1. COVID-19 Landscape: Diabetic Retinopathy Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Diabetic Retinopathy Market, By Type

8.1. Diabetic Retinopathy Market, by Type

8.1.1. Proliferative Diabetic Retinopathy

8.1.1.1. Market Revenue and Forecast

8.1.2. Non-Proliferative Diabetic Retinopathy

8.1.2.1. Market Revenue and Forecast

Chapter 9. Global Diabetic Retinopathy Market, By Age Group

9.1. Diabetic Retinopathy Market, by Age Group

9.1.1. 40-49

9.1.1.1. Market Revenue and Forecast

9.1.2. 65-74

9.1.2.1. Market Revenue and Forecast

9.1.3. 50-64

9.1.3.1. Market Revenue and Forecast

Chapter 10. Global Diabetic Retinopathy Market, By Management 

10.1. Diabetic Retinopathy Market, by Management

10.1.1. Vitrectomy

10.1.1.1. Market Revenue and Forecast

10.1.2. Anti-VEGF

10.1.2.1. Market Revenue and Forecast

10.1.3. Intracular Steroid Injection

10.1.3.1. Market Revenue and Forecast

10.1.4. Laser Surgery

10.1.4.1. Market Revenue and Forecast

Chapter 11. Global Diabetic Retinopathy Market, By Distribution Channel 

11.1. Diabetic Retinopathy Market, by Distribution Channel

11.1.1. Hospitals and Pharmacies

11.1.1.1. Market Revenue and Forecast

11.1.2. Ambulatory Surgical Centers (ASCs)

11.1.2.1. Market Revenue and Forecast

11.1.3. Eye Clinics

11.1.3.1. Market Revenue and Forecast

Chapter 12. Global Diabetic Retinopathy Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Type

12.1.2. Market Revenue and Forecast, by Age Group

12.1.3. Market Revenue and Forecast, by Management

12.1.4. Market Revenue and Forecast, by Distribution Channel

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Type

12.1.5.2. Market Revenue and Forecast, by Age Group

12.1.5.3. Market Revenue and Forecast, by Management

12.1.5.4. Market Revenue and Forecast, by Distribution Channel

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Type

12.1.6.2. Market Revenue and Forecast, by Age Group

12.1.6.3. Market Revenue and Forecast, by Management

12.1.6.4. Market Revenue and Forecast, by Distribution Channel

12.2. Europe

12.2.1. Market Revenue and Forecast, by Type

12.2.2. Market Revenue and Forecast, by Age Group

12.2.3. Market Revenue and Forecast, by Management

12.2.4. Market Revenue and Forecast, by Distribution Channel

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Type

12.2.5.2. Market Revenue and Forecast, by Age Group

12.2.5.3. Market Revenue and Forecast, by Management

12.2.5.4. Market Revenue and Forecast, by Distribution Channel

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Type

12.2.6.2. Market Revenue and Forecast, by Age Group

12.2.6.3. Market Revenue and Forecast, by Management

12.2.6.4. Market Revenue and Forecast, by Distribution Channel

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Type

12.2.7.2. Market Revenue and Forecast, by Age Group

12.2.7.3. Market Revenue and Forecast, by Management

12.2.7.4. Market Revenue and Forecast, by Distribution Channel

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Type

12.2.8.2. Market Revenue and Forecast, by Age Group

12.2.8.3. Market Revenue and Forecast, by Management

12.2.8.4. Market Revenue and Forecast, by Distribution Channel

12.3. APAC

12.3.1. Market Revenue and Forecast, by Type

12.3.2. Market Revenue and Forecast, by Age Group

12.3.3. Market Revenue and Forecast, by Management

12.3.4. Market Revenue and Forecast, by Distribution Channel

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Type

12.3.5.2. Market Revenue and Forecast, by Age Group

12.3.5.3. Market Revenue and Forecast, by Management

12.3.5.4. Market Revenue and Forecast, by Distribution Channel

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Type

12.3.6.2. Market Revenue and Forecast, by Age Group

12.3.6.3. Market Revenue and Forecast, by Management

12.3.6.4. Market Revenue and Forecast, by Distribution Channel

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Type

12.3.7.2. Market Revenue and Forecast, by Age Group

12.3.7.3. Market Revenue and Forecast, by Management

12.3.7.4. Market Revenue and Forecast, by Distribution Channel

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Type

12.3.8.2. Market Revenue and Forecast, by Age Group

12.3.8.3. Market Revenue and Forecast, by Management

12.3.8.4. Market Revenue and Forecast, by Distribution Channel

12.4. MEA

12.4.1. Market Revenue and Forecast, by Type

12.4.2. Market Revenue and Forecast, by Age Group

12.4.3. Market Revenue and Forecast, by Management

12.4.4. Market Revenue and Forecast, by Distribution Channel

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Type

12.4.5.2. Market Revenue and Forecast, by Age Group

12.4.5.3. Market Revenue and Forecast, by Management

12.4.5.4. Market Revenue and Forecast, by Distribution Channel

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Type

12.4.6.2. Market Revenue and Forecast, by Age Group

12.4.6.3. Market Revenue and Forecast, by Management

12.4.6.4. Market Revenue and Forecast, by Distribution Channel

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Type

12.4.7.2. Market Revenue and Forecast, by Age Group

12.4.7.3. Market Revenue and Forecast, by Management

12.4.7.4. Market Revenue and Forecast, by Distribution Channel

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Type

12.4.8.2. Market Revenue and Forecast, by Age Group

12.4.8.3. Market Revenue and Forecast, by Management

12.4.8.4. Market Revenue and Forecast, by Distribution Channel

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Type

12.5.2. Market Revenue and Forecast, by Age Group

12.5.3. Market Revenue and Forecast, by Management

12.5.4. Market Revenue and Forecast, by Distribution Channel

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Type

12.5.5.2. Market Revenue and Forecast, by Age Group

12.5.5.3. Market Revenue and Forecast, by Management

12.5.5.4. Market Revenue and Forecast, by Distribution Channel

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Type

12.5.6.2. Market Revenue and Forecast, by Age Group

12.5.6.3. Market Revenue and Forecast, by Management

12.5.6.4. Market Revenue and Forecast, by Distribution Channel

Chapter 13. Company Profiles

13.1. Bayer AG

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. ABBVIE INC.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Novartis AG

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Oxurion NV

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Sirnaomics

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Alimera Sciences

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Ampio Pharmaceuticals Inc.

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. BCNPeptides

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Kowa Company Ltd.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Genentech, Inc.

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global diabetic retinopathy market size is expected to increase USD 17.91 billion by 2034 from USD 9.61 billion in 2024.

The global diabetic retinopathy market will register growth rate of 6.42% between 2025 and 2034.

The major players operating in the diabetic retinopathy market are Bayer AG, ABBVIE INC., Novartis AG, Oxurion NV, Sirnaomics, Alimera Sciences, Ampio Pharmaceuticals Inc., BCNPeptides, Kowa Company Ltd., Genentech, Inc., and Others.

The driving factors of the diabetic retinopathy market are the increasing cases of diabetes and rising campaign for awareness of eye-related diseases.

North America region will lead the global diabetic retinopathy market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client